Last reviewed · How we verify
Upper limb spasticity
Approved treatments
- Nuceiva · GlaxoSmithKline K.K.
Nuceiva works by blocking the release of acetylcholine, a neurotransmitter that transmits signals from nerve cells to muscles, thereby reducing muscle spasms and contractions. - Xeomin · Merz Pharms
Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Upper limb spasticity patent landscape — cliff calendar, originator estates, attackable patents
- Upper limb spasticity treatment landscape brief
- Upper limb spasticity treatment updates RSS
Frequently asked questions about Upper limb spasticity
What drugs treat Upper limb spasticity?
Tracked treatments include Nuceiva, Xeomin.
What is the treatment for Upper limb spasticity?
Standard treatment for Upper limb spasticity includes Nuceiva, Xeomin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Upper limb spasticity patent cliff · Upper limb spasticity CI report
- Treatment: Nuceiva · GlaxoSmithKline K.K.
- Treatment: Xeomin · Merz Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing